Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes

Author(s): Amos Abioye*, Adekunle Sanyaolu, Paulina Dudzinska, Aderonke Ayinke Adepoju-Bello, Herbert A.B. Coker.

Journal Name: Pharmaceutical Nanotechnology

Volume 8 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Ciprofloxacin free base is practically insoluble in aqueous medium (0.0011 and 0.09 mg/mL at 25 and 37°C respectively). Its inorganic salt form (ciprofloxacin hydrochloride) is more soluble in water (1.35 mg/mL) however when administered orally, it exhibits decreased solubility in the stomach due to common ion effects. Ciprofloxacin free base was used in this study because of its greater hydrophobicity than its hydrochloride salt, which is required for effective permeability and potent antibacterial activity.

Objective: The purpose of this study is to enhance oral solubility and bacterial cell permeability of the free base ciprofloxacin (CPX) using a single step CPX-chitosan (CT) selfassembly to form nanoplexes with organic counterions. It was envisioned that this would allow the delivery of larger amounts of active drug into the microorganisms.

Methods: Ciprofloxacin-chitosan nanocomplex (nanoplex) was prepared using low energy electrostatic self-assembly technique previously described. Formation of eutectic nanoplex was confirmed using FTIR, DSC, TGA and SEM. The saturated solubility, in vitro release kinetics and mechanism of drug release were determined using mathematical models. Potency and synergism were determined from the inhibition zones, minimum inhibitory concentration (MIC) and Fractional Inhibitory Concentration (FIC) of the nanoplexes using Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.

Results: Formation of CPX-CT eutectic adduct polymeric nanoplexes was confirmed with FT-IR and DSC and SEM revealed the conversion of rod-like crystals of CPX (117 μm long) into spherical nanostructures (23-503 nm) dictated by pH, ionic strength and concentration of CT. The solubility of free base CPX increased to a maximum of 32.77 mg/mL compared to 0.0011-0.09 mg/mL reported in literature and dissolution efficiency increased to a maximum of 100% within 72 h. The synergistic effect of CT on antimicrobial activity of CPX was quantified, for the first time, using Fractional Inhibitory Concentration (FIC) of the nanoplexes. FIC was less than 0.5 in both Gram positive (0.031-0.250) and Gram negative (0.036-0.281) microorganisms used in this study, confirming synergistic enhancement of antimicrobial efficacy of CPX.

Conclusion: It is evident that the design of drug-polymer nanocomplex formulation provides a platform for the synergistic enhancement of therapeutic potency of antibiotics.

Keywords: Bacteriostatic chitosan, ciprofloxacin nanoplexes, extended potency, Fractional Inhibitory Concentrtion (FIC), in vitro drug release kinetics, synergistic antimicrobial activity.

[1]
Zhang GF, Liu X, Zhang S, Pan B, Liu ML. Ciprofloxacin derivatives and their antibacterial activities. Eur J Med Chem 2018; 146: 599-612.
[http://dx.doi.org/10.1016/j.ejmech.2018.01.078] [PMID: 29407984]
[2]
World Health Organization, Geneva. guidelines for the management of drug-resistant tuberculosis. world health organization, WHO/TB/96-210. 1997; Rev. 1.
[3]
Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative Bacilli. Clin Infect Dis 2005; 41(6): 848-54.
[http://dx.doi.org/10.1086/432803] [PMID: 16107985]
[4]
Amos Abioye GTC, Adeola T, Kola-Mustapha KR. Ken Beresford RA. Polymer-drug nanoconjugate-an innovative nanomedicine: challenges and recent advancements in rational formulation design for effective delivery of poorly soluble drugs. Pharm Nanotechnol 2016; 4(1): 38-79.
[http://dx.doi.org/10.2174/2211738504666160213001714]
[5]
Kutscher M, Cheow WS, Werner V, et al. Influence of salt type and ionic strength on self-assembly of dextran sulphate-ciprofloxacin nanoplexes. Int J Pharm 2015; 486: 21-9.
[http://dx.doi.org/10.1016/j.ijpharm.2015.03.022] [PMID: 25772413]
[6]
Mesallati H, Umerska A, Paluch KJ, Tajber L. Amorphous polymeric drug salts as ionic solid dispersion forms of ciprofloxacin. Mol Pharm 2017; 14(7): 2209-23.
[http://dx.doi.org/10.1021/acs.molpharmaceut.7b00039] [PMID: 28570079]
[7]
Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antibacterials. Int J Pharm 1990; 63: 237-50.
[http://dx.doi.org/10.1016/0378-5173(90)90130-V]
[8]
Surov AO, Manin AN, Voronin AP, et al. Pharmaceutical salts of ciprofloxacin with dicarboxylic acids. Eur J Pharm Sci 2015; 77: 112-21.
[http://dx.doi.org/10.1016/j.ejps.2015.06.004] [PMID: 26066411]
[9]
Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011; 420(1): 1-10.
[http://dx.doi.org/10.1016/j.ijpharm.2011.08.032] [PMID: 21884771]
[10]
Li S, Wong S, Sethia S, Almoazen H, Joshi YM, Serajuddin AT. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm Res 2005; 22(4): 628-35.
[http://dx.doi.org/10.1007/s11095-005-2504-z] [PMID: 15846471]
[11]
Zaki NMAP, Artursson P, Bergström CA. A modified physiological BCS for prediction of intestinal absorption in drug discovery. Mol Pharm 2010; 7(5): 1478-87.
[http://dx.doi.org/10.1021/mp100124f] [PMID: 20734997]
[12]
Cao XLZQH, Pan XHCZ, Lϋ J. Mechanochemical synthesis of nano-ciprofloxacin with enhanced antibacterial activity. Inorg Chem Commun 2019; 102: 66-9.
[http://dx.doi.org/10.1016/j.inoche.2019.02.015]
[13]
Paluch KJ, McCabe T, Müller-Bunz H, Corrigan OI, Healy AM, Tajber L. Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. Mol Pharm 2013; 10(10): 3640-54.
[http://dx.doi.org/10.1021/mp400127r] [PMID: 23947816]
[14]
Kola-Mustapha AT, Armitage D, Abioye AO. Development of aqueous ternary nanomatrix films: a novel ‘green’ strategy for the delivery of poorly soluble drugs. Int J Pharm 2016; 515(1-2): 616-31.
[http://dx.doi.org/10.1016/j.ijpharm.2016.11.017] [PMID: 27825861]
[15]
Abioye AO, Issah S, Kola-Mustapha AT. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen. Int J Pharm 2015; 490(1-2): 112-30.
[http://dx.doi.org/10.1016/j.ijpharm.2015.05.030] [PMID: 25997660]
[16]
Abioye AO, Armitage R, Kola-Mustapha AT. Kola-Mustapha. Thermodynamic changes induced by intermolecular interaction between ibuprofen and chitosan: effect on crystal habit, solubility and in vitro release kinetics of ibuprofen. Pharm Res 2016; 33(2): 337-57.
[http://dx.doi.org/10.1007/s11095-015-1793-0] [PMID: 26404641]
[17]
Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Eur J Pharm Biopharm 2013; 85(3 Pt B): 873-81.
[http://dx.doi.org/10.1016/j.ejpb.2013.03.014] [PMID: 23537574]
[18]
Dengale SJGH, Grohganz H, Rades T, Löbmann K. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev 2016; 100: 116-25.
[http://dx.doi.org/10.1016/j.addr.2015.12.009] [PMID: 26805787]
[19]
ElShaer AOP, Hanson PMAR. Preparation and evaluation of amino acid based salt forms of model zwitter ionic drug ciprofloxacin. Phar Drug Deliv Res 2013; 2: 1-10.
[20]
Adepoju-Bello AA, Coker HA, Eboka CJ, Abioye AO, Ayoola GA. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex. Nig Q J Hosp Med 2008; 18(3): 133-6.
[PMID: 19062475]
[21]
Mullen DG, Fang M, Desai A, Baker JR, Orr BG, Banaszak Holl MM. A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano 2010; 4(2): 657-70.
[http://dx.doi.org/10.1021/nn900999c] [PMID: 20131876]
[22]
Bajaj G, Van Alstine WG, Yeo Y. Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release. PLoS One 2012; 7(1): e30899
[http://dx.doi.org/10.1371/journal.pone.0030899] [PMID: 22292072]
[23]
Rao SBSCP, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 1997; 34(1): 21-8.
[http://dx.doi.org/10.1002/(SICI)1097-4636(199701)34:1<21:AID-JBM4>3.0.CO;2-P] [PMID: 8978649]
[24]
Muzzarelli RA, Mattioli-Belmonte M, Pugnaloni A, Biagini G. Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. EXS 1999; 87: 251-64.
[http://dx.doi.org/10.1007/978-3-0348-8757-1_18] [PMID: 10906965]
[25]
Kong M, Chen XG, Xing K, Park HJ. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int J Food Microbiol 2010; 144(1): 51-63.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2010.09.012] [PMID: 20951455]
[26]
Mostafa AAE-S, El-Sayed MMH, Mahmoud AA, Gamal-Eldeen AM. Bioactive/Natural polymeric scaffolds loaded with ciprofloxacin for treatment of osteomyelitis. AAPS PharmSciTech 2017; 18(4): 1056-69.
[http://dx.doi.org/10.1208/s12249-016-0605-0] [PMID: 27520562]
[27]
Luo Y, Wang Q. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery. Int J Biol Macromol 2014; 64: 353-67.
[http://dx.doi.org/10.1016/j.ijbiomac.2013.12.017] [PMID: 24360899]
[28]
Das D, Pal S. Dextrin/poly (HEMA): pH responsive porous hydrogel for controlled release of ciprofloxacin. Int J Biol Macromol 2015; 72: 171-8.
[http://dx.doi.org/10.1016/j.ijbiomac.2014.08.007] [PMID: 25138539]
[29]
Mesallati H, Conroy D, Hudson S, Tajber L. Preparation and characterization of amorphous ciprofloxacin-amino acid salts. Eur J Pharm Biopharm 2017; 121: 73-89.
[http://dx.doi.org/10.1016/j.ejpb.2017.09.009] [PMID: 28919470]
[30]
Sobhani Z, Samani SM, Montaseri H, Khezri E. Nanoparticles of chitosan loaded ciprofloxacin: fabrication and antimicrobial activity. Adv Pharm Bull 2017; 7(3): 427-32.
[http://dx.doi.org/10.15171/apb.2017.051] [PMID: 29071225]
[31]
Abioye AOASA, Bamiro SBOE. In vitro kinetics of staphylococcal death in the stem bark extracts of Jatropha curcas Linn (Euphorbiaceae). CJPAS 2011; 5(2): 1465-74.
[32]
Abioye AO, Kola-Mustapha A. Controlled electrostatic self-assembly of ibuprofen-cationic dextran nanoconjugates prepared by low energy green process-a novel delivery tool for poorly soluble drugs. Pharm Res 2015; 32(6): 2110-31.
[http://dx.doi.org/10.1007/s11095-014-1603-0] [PMID: 25527142]
[33]
Abioye ATCG, Simone ENZ. Real-time monitoring of the influence of in situ granulation on aqueous crystallization of ibuprofen in ibuprofen-cationic dextran crystanules using crystallization process informatics system (CryPRINS). Int J Pharm 2016; 509: 264-78.
[http://dx.doi.org/10.1016/j.ijpharm.2016.05.066] [PMID: 27260131]
[34]
Abioye AO, Kola-Mustapha A, Chi GT, Ilya S. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules. Int J Pharm 2014; 471(1-2): 453-77.
[http://dx.doi.org/10.1016/j.ijpharm.2014.05.053] [PMID: 24886691]
[35]
Abioye AOOOM, Coker HABASA, Bamiro SB A L. Comparative evaluation of in-vitro activity of amoxicillin-cloxacillin combination against clinical isolates of staphylococcus aureus. Nig Q J Hosp Med 2004; 14(2): 199-205.
[36]
Clinical and Laboratory Standards Institute. USA: Clinical and Laboratory Standards Institute; 2007. (Performance Standards for Antimicrobial Susceptibility testing). Report No: M100-S17-1.
[37]
Eliopoulos G. Antimicrobial combinations. 4th ed. Baltimore: Williams and Wilkins 1996; pp. 330-42.
[38]
Yandell BS. Practical Data Analysis for Designed Experiments. FL, US: Chapman and Hall 1997.
[http://dx.doi.org/10.1007/978-1-4899-3035-4]
[39]
Yuksel N, Kanik AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and independent methods. Int J Pharm 2000; 209(1-2): 57-67.
[http://dx.doi.org/10.1016/S0378-5173(00)00554-8] [PMID: 11084246]
[40]
Palacio DA. RBL, Urbano B. F. Ultrafiltration membranes with three water-soluble polyelectrolyte copolymers to remove ciprofloxacin from aqueous systems. Chem Eng J 2018; 351: 85-93.
[http://dx.doi.org/10.1016/j.cej.2018.06.099]
[41]
Sathigari SKOCA, Ober CA, Sanganwar GP, Gupta RB, Babu RJ. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement. J Pharm Sci 2011; 100(7): 2952-65.
[http://dx.doi.org/10.1002/jps.22524] [PMID: 21344415]
[42]
Sanganwar GPGRB. Nano-mixing of dipyridamole drug and excipient nanoparticles by sonication in liquid CO2. Powder Technol 2009; 196(1): 36-49.
[http://dx.doi.org/10.1016/j.powtec.2009.06.015]
[43]
Sahoo S, Chakraborti CK, Naik S, Mishra SC, Nanda UN. Structural analysis of ciprofloxacin-carbopol polymeric composites by x-ray diffraction and Fourier transform infra-red spectroscopy. Trop J Pharm Res 2011; 10(3): 273-80.
[http://dx.doi.org/10.4314/tjpr.v10i3.14]
[44]
Coates J. Interpretation of infrared spectra, A practical approach. In: Meyers RA, Ed. Encyclopedia of analytical chemistry. Wiley: Hoboken, NJ 2000; pp. 10815-37.
[45]
Semwal ASB, Archana DVA, Dutta PK. Macromolecular chitosan/ ciprofloxacin pro-drugs: synthesis, physico-chemical and biological assessment for drug delivery systems. J Polymer Mater 2012; 29(1): 1-13.
[46]
Bradley JCWA. Lang A Open Melting Point Dataset. figshare.Dataset.2014.
[http://dx.doi.org/10.6084/m9.figshare.1031637.v2]
[47]
Yu X, Zipp GL, Davidson GW III. The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion. Pharm Res 1994; 11(4): 522-7.
[http://dx.doi.org/10.1023/A:1018910431216] [PMID: 8058609]
[48]
Dong YRY, Wang HZY, Bi D. Studies on glass transition temperature of chitosan with four techniques. J Appl Polym Sci 2004; 93(4): 1553-8.
[http://dx.doi.org/10.1002/app.20630]
[49]
Hanna DHSGR, Saad GR. Encapsulation of ciprofloxacin within modified xanthan gum-chitosan based hydrogel for drug delivery. Bioorg Chem 2019; 84: 115-24.
[http://dx.doi.org/10.1016/j.bioorg.2018.11.036] [PMID: 30500521]
[50]
Rathore HSST, Vasantharaja RALS, Prakash DSUT, Gupta S. Fabrication and characterization of chitosan film impregnated ciprofloxacin drug: a comparative study. Biocatal Agric Biotechnol 2019; 18: 101078
[http://dx.doi.org/10.1016/j.bcab.2019.101078]
[51]
Marei N, Elwahy AHM, Salah TA, El Sherif Y, El-Samie EA. Enhanced antibacterial activity of Egyptian local insects’ chitosan-based nanoparticles loaded with ciprofloxacin-HCl. Int J Biol Macromol 2019; 126: 262-72.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.12.204] [PMID: 30584935]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 1
Year: 2020
Page: [33 - 53]
Pages: 21
DOI: 10.2174/2211738507666191021102256
Price: $65

Article Metrics

PDF: 19
HTML: 3